SCHEMBL25754575

SCHEMBL25754575

CCOc1c(F)c(F)cc(C(=O)Nc2ccc(OC)c(S(=O)(=O)Nc3c(C)cccc3C)c2)c1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.51
SMN1; SMN2 Q16637 6/20 0.51
MEN1 O00255 6/20 0.51
GAA P10253 5/20 0.51
ALDH1A1 P00352 4/20 0.51
LMNA P02545 3/20 0.51
ALOX12 P18054 1/20 0.51
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
MAPT P10636 6/20 0.48
HTT P42858 1/20 0.48
HPGD P15428 2/20 0.48
POLB P06746 2/20 0.45
KDM4E B2RXH2 2/20 0.44
RECQL P46063 1/20 0.44
CASP6 P55212 1/20 0.42
KCNK3 O14649 1/20 0.42
KCNK9 Q9NPC2 1/20 0.42
TNF P01375 1/20 0.42
NOD2 Q9HC29 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23846362 0.87 SMN1; SMN2 (0.57) KMT2ASMN1; SMN2MEN1GAAALDH1A1
SCHEMBL25754548 0.80 MEN1 (0.53) KMT2ASMN1; SMN2MEN1GAAALDH1A1
SCHEMBL25755371 0.78 KMT2A (0.48) KMT2ASMN1; SMN2MEN1GAAALDH1A1
SCHEMBL25754571 0.78 SMN1; SMN2 (0.55) KMT2ASMN1; SMN2MEN1GAAALDH1A1
SCHEMBL23846602 0.77 LMNA (0.49) KMT2ASMN1; SMN2MEN1GAAALDH1A1
SCHEMBL23846533 0.76 LMNA (0.56) KMT2ASMN1; SMN2MEN1GAAALDH1A1
SCHEMBL23846515 0.76 KCNK3 (0.53) KMT2ASMN1; SMN2MEN1GAAALDH1A1
SCHEMBL25754559 0.76 KMT2A (0.55) KMT2ASMN1; SMN2MEN1GAAALDH1A1
SCHEMBL23846421 0.75 SMN1; SMN2 (0.49) KMT2ASMN1; SMN2MEN1GAAALDH1A1
SCHEMBL23846588 0.75 KMT2A (0.49) KMT2ASMN1; SMN2MEN1GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 KMT2A 4864/4885SMN1; SMN2 405/4885MEN1 3902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.